BIOMOTION PHARMA ApS: Financial statements 2017
CVR: 12928203
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK -999.
- Profit/Loss
- DKK 0
- Equity
- DKK -999
- Total Assets
- DKK 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | 0 | -999 | - |
| 2016 | - | 0 | 0 | -999 | - |
| 2015 | - | 3 t. | -2 t. | -999 | - |
| 2014 | - | -999 | -999 | 983 | - |
| 2013 | - | 3 t. | 3 t. | 2 t. | - |
Official annual report
Keep an eye on BIOMOTION PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOMOTION PHARMA ApS
BIOMOTION PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company is in liquidation. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Michael Rasmussen. The company is owned by Michael Rasmussen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,000 and a net result of DKK -4,202 compared with DKK -6,460 the year before. Equity in the 2025 report amounted to DKK -892.